CA
CDMO

Cetera Advisors’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Cetera Advisors’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,505
Closed -$218K – 1478
2021
Q2 		$218K Buy
+8,505
New +$182K 0.01% 1194

Other funds holding CDMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Cetera Advisors's CDMO Position: Q3 2021 in Review

Cetera Advisors sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2021, closing a stake of 8,505 shares — an estimated $218K sold.

Cetera Advisors first reported a position in CDMO in Q2 2021 and held it in 1 quarter. The position peaked at $218K in Q2 2021. 161 funds tracked by Wall St. Rank hold CDMO as of Q3 2021.

  • Cetera Advisors reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Cetera Advisors sold 8,505 Avid Bioservices, Inc. Common Stock shares in Q3 2021, an estimated $218K.
  • Cetera Advisors first reported a position in Avid Bioservices, Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Cetera Advisors's Avid Bioservices, Inc. Common Stock position peaked at $218K in Q2 2021.
  • 161 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2021.

Based on Cetera Advisors's 13F filing for Q3 2021, filed 16 Nov 2021.